English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Hepatitis B (HBV) is a significant liver disease that affects roughly 400 million individuals globally with chronic infection, leading to liver cirrhosis or carcinoma. The virus can spread through blood transfusion, sexual contact, or the use of contaminated needles. HBV is more prevalent in developing countries than developed ones. However, it is estimated that 5% to 10% of the global population carry the virus, whereas, in North America and western Europe, only 1% of the people have a chronic infection. Our objective is to determine the prevalence of HBV and identify the disease’s risk factors. We conducted a statistical study, and data were collected through the Al Zzawia street hospital from November 1, 2010, to January 1, 2011. Our results concluded that the prevalence of HbsAg was higher in 2005 than in 2010. HBV was also found to be more prevalent in males than in females. As a result, more attention and guidance, especially for young people, could reduce the spread drastically.

Carried hepatitis B among Libyan patients who attended the Al Zawia street hospital